Alexandria Venture Investments, LLC

See Remarks at ENVIVIO INC · on record since Jun 8, 2023
10% owner at Singular Genomics Systems, Inc. · on record since May 26, 2021
10% owner at ACTELIS NETWORKS INC · on record since Nov 20, 2017
10% owner at Evelo Biosciences, Inc. · on record since May 21, 2018
10% owner at Liquidia Technologies Inc · on record since Jul 25, 2018
10% owner at CONSTELLATION PHARMACEUTICALS INC · on record since Jul 23, 2018
10% owner at IDEAYA Biosciences, Inc. · on record since May 30, 2019
10% owner at Karuna Therapeutics, Inc. · on record since Jun 27, 2019
10% owner at Applied Therapeutics, Inc. · on record since May 20, 2019
10% owner at NextCure, Inc. · on record since May 13, 2019
10% owner at Korro Bio, Inc. · on record since Oct 9, 2019
10% owner at Enliven Therapeutics, Inc. · on record since Mar 16, 2020
10% owner at Kymera Therapeutics, Inc. · on record since Aug 25, 2020
10% owner at Relay Therapeutics, Inc. · on record since Jul 20, 2020
10% owner at Metacrine, Inc. · on record since Sep 18, 2020
10% owner at Vor Biopharma Inc. · on record since Feb 9, 2021
10% owner at Xilio Therapeutics, Inc. · on record since Oct 26, 2021
10% owner at Vigil Neuroscience, Inc. · on record since Jan 11, 2022
10% owner at · on record since Jun 16, 2020
10% owner at · on record since Dec 8, 2020

Insider trading activity of Alexandria Venture Investments, LLC

Transactions on record: 78; since Nov 20, 2017

Open-market buys: 7; $7.5M

Open-market sells: 0

Companies traded: 19; last filing Oct 16, 2023

Figures computed from official regulatory filings — .

Companies where Alexandria Venture Investments, LLC has traded

12 tx · $5M · Oct 16, 2023
3 tx · Jan 11, 2022
2 tx · Oct 26, 2021
3 tx · Jun 1, 2021
2 tx · Feb 9, 2021
3 tx · Dec 8, 2020
5 tx · $500K · Sep 18, 2020
3 tx · Aug 25, 2020
4 tx · Jul 20, 2020
4 tx · Jun 16, 2020
4 tx · Mar 16, 2020
3 tx · Oct 9, 2019
3 tx · $480K · Jul 5, 2019
4 tx · $500K · May 30, 2019
5 tx · May 13, 2019

Track record of Alexandria Venture Investments, LLC

Statistical track record

Free account

Open-market buys: 11

Last buy: Jun 27, 2022

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Alexandria Venture Investments, LLC

Co-insiders of Alexandria Venture Investments, LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Applied Therapeutics, Inc.Listing unverified	Oct 16, 2023	OtherD (derivative)	-615,000	—	n/a (No price was disclosed in the filing)		SEC
Applied Therapeutics, Inc.Listing unverified	Oct 16, 2023	Other	-1,600,000	—	n/a (No price was disclosed in the filing)		SEC
Applied Therapeutics, Inc.Listing unverified	Oct 16, 2023	OtherD (derivative)	615,000	—	n/a (No price was disclosed in the filing)		SEC
Applied Therapeutics, Inc.Listing unverified	Oct 16, 2023	Other	1,600,000	—	n/a (No price was disclosed in the filing)		SEC
Applied Therapeutics, Inc.Listing unverified	Jun 29, 2022	Buy	2,065,000	1.00 USD	$2.1M	conv 76Unusual sizeFirst in 12mo	SEC
Applied Therapeutics, Inc.Listing unverified	Jun 29, 2022	BuyD (derivative)	2,050,000	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Applied Therapeutics, Inc.Listing unverified	Jun 29, 2022	Buy	1,435,000	1.00 USD	$1.4M	conv 65First in 12mo	SEC
Applied Therapeutics, Inc.Listing unverified	Jun 29, 2022	BuyD (derivative)	615,000	1.00 USD	$615K	First in 12mo	SEC
Applied Therapeutics, Inc.Listing unverified	Jun 29, 2022	BuyD (derivative)	885,000	1.00 USD	$885K	First in 12mo	SEC
Applied Therapeutics, Inc.Listing unverified	Jun 29, 2022	BuyD (derivative)	2,950,000	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Applied Therapeutics, Inc.Listing unverified	Feb 25, 2022	Other	300,000	—	n/a (No price was disclosed in the filing)		SEC
Applied Therapeutics, Inc.Listing unverified	Feb 25, 2022	Other	-300,000	—	n/a (No price was disclosed in the filing)		SEC
Vigil Neuroscience, Inc.Listing unverified	Jan 11, 2022	Other	192,973	—	n/a (No price was disclosed in the filing)		SEC
Vigil Neuroscience, Inc.Listing unverified	Jan 11, 2022	OtherD (derivative)	-142,539	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vigil Neuroscience, Inc.Listing unverified	Jan 11, 2022	OtherD (derivative)	-392,618	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	OtherD (derivative)	-1,581,026	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	Other	166,423	—	n/a (No price was disclosed in the filing)		SEC
Singular Genomics Systems, Inc.Listing unverified	Jun 1, 2021	OtherD (derivative)	-1,796,684	—	n/a (No price was disclosed in the filing)		SEC
Singular Genomics Systems, Inc.Listing unverified	Jun 1, 2021	OtherD (derivative)	-849,301	—	n/a (No price was disclosed in the filing)		SEC
Singular Genomics Systems, Inc.Listing unverified	Jun 1, 2021	Other	2,645,985	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	Other	282,804	—	n/a (No price was disclosed in the filing)		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	OtherD (derivative)	-3,846,152	—	n/a (No price was disclosed in the filing)		SEC
ARS Pharmaceuticals, Inc.Listing on record	Dec 8, 2020	OtherD (derivative)	-1,428,570	—	n/a (No price was disclosed in the filing)		SEC
ARS Pharmaceuticals, Inc.Listing on record	Dec 8, 2020	OtherD (derivative)	-1,168,347	—	n/a (No price was disclosed in the filing)		SEC
ARS Pharmaceuticals, Inc.Listing on record	Dec 8, 2020	Other	699,412	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Applied Therapeutics, Inc.Listing unverified	Oct 16, 2023	OtherD (derivative)	-615,000	—	n/a (No price was disclosed in the filing)		SEC
Applied Therapeutics, Inc.Listing unverified	Oct 16, 2023	Other	-1,600,000	—	n/a (No price was disclosed in the filing)		SEC
Applied Therapeutics, Inc.Listing unverified	Oct 16, 2023	OtherD (derivative)	615,000	—	n/a (No price was disclosed in the filing)		SEC
Applied Therapeutics, Inc.Listing unverified	Oct 16, 2023	Other	1,600,000	—	n/a (No price was disclosed in the filing)		SEC
Applied Therapeutics, Inc.Listing unverified	Jun 29, 2022	Buy	2,065,000	1.00 USD	$2.1M	conv 76Unusual sizeFirst in 12mo	SEC
Applied Therapeutics, Inc.Listing unverified	Jun 29, 2022	BuyD (derivative)	2,050,000	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Applied Therapeutics, Inc.Listing unverified	Jun 29, 2022	Buy	1,435,000	1.00 USD	$1.4M	conv 65First in 12mo	SEC
Applied Therapeutics, Inc.Listing unverified	Jun 29, 2022	BuyD (derivative)	615,000	1.00 USD	$615K	First in 12mo	SEC
Applied Therapeutics, Inc.Listing unverified	Jun 29, 2022	BuyD (derivative)	885,000	1.00 USD	$885K	First in 12mo	SEC
Applied Therapeutics, Inc.Listing unverified	Jun 29, 2022	BuyD (derivative)	2,950,000	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Applied Therapeutics, Inc.Listing unverified	Feb 25, 2022	Other	300,000	—	n/a (No price was disclosed in the filing)		SEC
Applied Therapeutics, Inc.Listing unverified	Feb 25, 2022	Other	-300,000	—	n/a (No price was disclosed in the filing)		SEC
Vigil Neuroscience, Inc.Listing unverified	Jan 11, 2022	Other	192,973	—	n/a (No price was disclosed in the filing)		SEC
Vigil Neuroscience, Inc.Listing unverified	Jan 11, 2022	OtherD (derivative)	-142,539	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vigil Neuroscience, Inc.Listing unverified	Jan 11, 2022	OtherD (derivative)	-392,618	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	OtherD (derivative)	-1,581,026	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 26, 2021	Other	166,423	—	n/a (No price was disclosed in the filing)		SEC
Singular Genomics Systems, Inc.Listing unverified	Jun 1, 2021	OtherD (derivative)	-1,796,684	—	n/a (No price was disclosed in the filing)		SEC
Singular Genomics Systems, Inc.Listing unverified	Jun 1, 2021	OtherD (derivative)	-849,301	—	n/a (No price was disclosed in the filing)		SEC
Singular Genomics Systems, Inc.Listing unverified	Jun 1, 2021	Other	2,645,985	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	Other	282,804	—	n/a (No price was disclosed in the filing)		SEC
Vor Biopharma Inc.Listing on record	Feb 9, 2021	OtherD (derivative)	-3,846,152	—	n/a (No price was disclosed in the filing)		SEC
ARS Pharmaceuticals, Inc.Listing on record	Dec 8, 2020	OtherD (derivative)	-1,428,570	—	n/a (No price was disclosed in the filing)		SEC
ARS Pharmaceuticals, Inc.Listing on record	Dec 8, 2020	OtherD (derivative)	-1,168,347	—	n/a (No price was disclosed in the filing)		SEC
ARS Pharmaceuticals, Inc.Listing on record	Dec 8, 2020	Other	699,412	—	n/a (No price was disclosed in the filing)		SEC